E815
TEAS SECTION 8 & 15 RECEIVED
07/13/2026
Back to search
Official data from USPTO
SURMODICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SURMODICS
ST13
US500000087083372Class
1, 2, 5, 9, 10, 40, 42
Filing
87083372
Registration
6102316
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
07/13/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 2, 5, 9, 10, 40, 42
Filing date
06/24/2016
Registration date
07/14/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2020
Last transaction
07/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
1999-08-00
First use in commerce
1999-08-00
Drawing code
4
Owner type
03
Owner location
Eden Prairie, MN, US
Examiner
FRUM MILONE, MARCIE R
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Surmodics, Inc.
Representatives
Scott W. Johnston MERCHANT & GOULD P.C.
Technical classification
Nice Classes
Class 1Class 2Class 5Class 9Class 10Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrialincluding medicaluse; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals namelya chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial usefor use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay componentsDNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devicescoatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices
Class 2
Medical device coatings; Coatings for biological and surgical implantsfor providing a lubricious and biocompatible surfacesold separately from the implants; Coatings for medical devicesfor delivery of a wide range of pharmaceuticalssold separately from the medical devices; Chemical coatings used in the manufacture of medical devices; Medical device coatings for coronaryperipheralneurovascular or heart devices; lubricious coatings for medical devices; Hemocompatible Coatings for medical devices
Class 5
Chemical preparations for medical purposesfor coating medical devices and delivering medicine for the treatment of vascular disease; Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticalscells and tissue; Chemical reagents for medical or veterinary purposes
Class 9
Microarray slides for scientificlaboratory or medical research use; beadsmembranesplates and surfaces for scientific research use; customizable polymer surfaces that immobilize or attach target biomolecules to the surface while preventing adsorption of unwanted biomolecules to the surfacesold as an integral component of all the aforesaid goods
Class 10
Medical devices and apparatuscatheters and drug eluting balloon catheters; Medical devicesstents that contain and deliver a wide range of pharmaceuticals; coatings for orthopedic implantsocular implants and surgical implants comprised of artificial materialssold as an integral part of the implantsfor the delivery of a wide range of pharmaceuticals; Coatings sold as an integral component of medical stents and other implantable medical devicescoatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; Medical devicescoronary stent systems; Medical devicesangioplasty catheters; Medical devicesmedical device Access systems; Medical deviceschronic total occlusion devices; Medical devicesembolic protection device; Medical deviceshemostasis introducer sheath; Medical devicesinterventional micro-catheter
Class 40
Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others; consulting about custom manufacturing medical and surgical devices; consulting in the field of medical devices related to manufacturing coaxial guide catheters
Class 42
Research and development services in the field of chemical analysis tests and procedures; Research and development of new products for others in the fields of pharmaceuticals and medical and surgical devices; scientific and research consultation and product research in the fields of pharmaceuticals and medical and surgical devices; product development consultation in the fields of pharmaceuticals and medical and surgical devices; scientific and research consulting in the field of medical devices and medical device coatings and medical device drug delivery systems; scientific and research consulting in the fields of conducting medical pre-clinical studies and clinical trials; consulting in the field of quality control for medical devices and testing for quality control; Custom design of medical device coatings for others; Testing services for medical devices and medical device coatings; medical device testing for DurabilityShelf-lifeaging studies process reproducibilitycoating morphology consistencyDefect analysisimpuritiescontaminantsdrug release mechanisms; diagnostic services in the field of medical devices and coatings; Consulting in the field of medical devices related to design and development of coaxial guide catheter
Publications
History of USPTO decisions and trademark events.
63 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/09/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/02/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/11/2019
GNFR
FINAL REFUSAL E-MAILED
12/11/2019
CNFR
SU - FINAL REFUSAL - WRITTEN
12/11/2019
CNFR
SU - FINAL REFUSAL - WRITTEN
12/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2019
ALIE
ASSIGNED TO LIE
11/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2019
GNRT
NON-FINAL ACTION E-MAILED
09/13/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/13/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/07/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/07/2019
IUAF
USE AMENDMENT FILED
08/08/2019
EISU
TEAS STATEMENT OF USE RECEIVED
08/08/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2019
EX3G
SOU EXTENSION 3 GRANTED
02/08/2019
EXT3
SOU EXTENSION 3 FILED
02/08/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/09/2018
EX2G
SOU EXTENSION 2 GRANTED
08/07/2018
EXT2
SOU EXTENSION 2 FILED
08/07/2018
EEXT
SOU TEAS EXTENSION RECEIVED
08/07/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/01/2018
EX1G
SOU EXTENSION 1 GRANTED
01/30/2018
EXT1
SOU EXTENSION 1 FILED
01/30/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/30/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/13/2017
PUBO
PUBLISHED FOR OPPOSITION
06/13/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/24/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
04/28/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/28/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
04/28/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/28/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/27/2016
GNRT
NON-FINAL ACTION E-MAILED
11/27/2016
CNRT
NON-FINAL ACTION WRITTEN
11/27/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/09/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/01/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/17/2016
ALIE
ASSIGNED TO LIE
10/17/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/30/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/30/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/30/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/30/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/30/2016
DOCK
ASSIGNED TO EXAMINER
09/30/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/29/2016
NWAP
NEW APPLICATION ENTERED
06/28/2016
Continuous trademark protection
Get notified about every new filing that threatens SURMODICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.